Transcriptomic analysis in liver spheroids identifies a dog-specific mechanism of hepatotoxicity for amcenestrant
Toxicological Sciences · 01.04.2025 · 204 (2) · 228-241
DOI: 10.1093/toxsci/kfaf012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 30.01.2025. Verfasst von Piyush Bajaj und 6 weiteren Autor:innen. Beteiligte Einrichtung: Global Investigative Toxicology, Preclinical Safety, Sanofi, Cambridge, MA 02141, United States. Hauptthemen laut MEDLINE: Liver, Gene Expression Profiling, Spheroids, Cellular, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Sanofi.
Abstract (Originalsprache)
Therapeutic drugs can sometimes cause adverse effects in a nonclinical species that do not translate to other species, including human. Species-specific (rat, dog, and human) in vitro liver spheroids were employed to understand the human relevance of cholestatic liver injury observed with a selective estrogen receptor degrader (amcenestrant) in dog, but not in rat, during preclinical development. Amcenestrant showed comparable cytotoxicity in liver spheroids from all 3 species; however, its M5 metabolite (RA15400562) showed dog preferential cytotoxicity after 7 days of treatment. Whole genome transcript profiles generated from liver spheroids revealed downregulation of genes related to bile acid synthesis and transport indicative of strong farnesoid X receptor (FXR) antagonism following treatment with both amcenestrant and its M5 metabolite in the dog but not in rat or human. In human spheroids, upregulation of genes for detoxification enzymes indicative of pregnane X receptor (PXR) agonism was observed following amcenestrant treatment, whereas in the dog these genes were downregulated. The M5 metabolite showed gene dysregulation indicating PXR agonism in both rat and human, and antagonism in dog. Analysis of liver samples from a 3-mo dog toxicity study conducted with amcenestrant showed downregulation of several genes associated with PXR and FXR, corroborating the in vitro results. These results support the hypothesis that dogs are uniquely susceptible to cholestatic hepatotoxicity following administration of amcenestrant due to species-specific antagonism of FXR and highlight the value of in vitro liver spheroids to investigating mechanisms of toxicity and possible species differences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Global Investigative Toxicology, Preclinical Safety, Sanofi, Cambridge, MA 02141, United States.
- Preclincial Safety, Sanofi, Montpellier 34070, France.
- Precision Medicine and Computational Biology, Sanofi, Cambridge, MA 02141, United States.
- Genetic Medicine Unit, Sanofi, Waltham, MA 02451, United States.
ORCID-Profile: Richard J Brennan
Förderung
- Sanofi
Zitieren
APA
Bajaj, P., Brennan, R. J., Laurent, S., Sauzeat, S., Dufault, M., Richards, B., & Adkins, K. (2025). Transcriptomic analysis in liver spheroids identifies a dog-specific mechanism of hepatotoxicity for amcenestrant. Toxicological Sciences, 204(2), 228-241. https://doi.org/10.1093/toxsci/kfaf012
Vancouver
Bajaj P, Brennan RJ, Laurent S, Sauzeat S, Dufault M, Richards B, et al. Transcriptomic analysis in liver spheroids identifies a dog-specific mechanism of hepatotoxicity for amcenestrant. Toxicological Sciences. 2025;204(2):228-241. doi:10.1093/toxsci/kfaf012
BibTeX
@article{Bajaj2025,
author = {Bajaj, Piyush and Brennan, Richard J and Laurent, Sébastien and Sauzeat, Sylvie and Dufault, Michael and Richards, Brenda and Adkins, Karissa},
title = {Transcriptomic analysis in liver spheroids identifies a dog-specific mechanism of hepatotoxicity for amcenestrant},
journal = {Toxicological Sciences},
year = {2025},
volume = {204},
number = {2},
pages = {228--241},
doi = {10.1093/toxsci/kfaf012}
}
EUVIMED